case_images: PMC4427155_01
case_images: Kinetics of viral load (red solid line) and Scr (blue dashed line) in 5 patients with CMV viremia after antiviral prophylaxis treated with leflunomide and other antiviral agents. The horizontal axis in each frame shows the time course in days after renal transplant (Tx). The duration of antiviral prophylaxis and therapy with different antiviral agents is indicated by horizontal bars on the top of each frame. PPX = Prophylaxis (gray bars); GCV/VGCV (purple bars); LEF = leflunomide (orange bars); FOS = foscarnet (green bars); CID = brincidofovir (red bar).
case_images: cnd-0005-0096-g01.jpg
case_images: PMC4427155_05_cnd-0005-0096-g01.jpg
case_images: F1
case_images: HTN underwent a SPK in May 2001 (fig. 1e).
case_images: PMC4427155_02
case_images: Kinetics of viral load (red solid line) and Scr (blue dashed line) in 5 patients with CMV viremia after antiviral prophylaxis treated with leflunomide and other antiviral agents. The horizontal axis in each frame shows the time course in days after renal transplant (Tx). The duration of antiviral prophylaxis and therapy with different antiviral agents is indicated by horizontal bars on the top of each frame. PPX = Prophylaxis (gray bars); GCV/VGCV (purple bars); LEF = leflunomide (orange bars); FOS = foscarnet (green bars); CID = brincidofovir (red bar).
case_images: cnd-0005-0096-g01.jpg
case_images: PMC4427155_05_cnd-0005-0096-g01.jpg
case_images: F1
case_images: HTN underwent a SPK in May 2001 (fig. 1e).
case_images: PMC4427155_03
case_images: Kinetics of viral load (red solid line) and Scr (blue dashed line) in 5 patients with CMV viremia after antiviral prophylaxis treated with leflunomide and other antiviral agents. The horizontal axis in each frame shows the time course in days after renal transplant (Tx). The duration of antiviral prophylaxis and therapy with different antiviral agents is indicated by horizontal bars on the top of each frame. PPX = Prophylaxis (gray bars); GCV/VGCV (purple bars); LEF = leflunomide (orange bars); FOS = foscarnet (green bars); CID = brincidofovir (red bar).
case_images: cnd-0005-0096-g01.jpg
case_images: PMC4427155_05_cnd-0005-0096-g01.jpg
case_images: F1
case_images: HTN underwent a SPK in May 2001 (fig. 1e).
case_images: PMC4427155_04
case_images: Kinetics of viral load (red solid line) and Scr (blue dashed line) in 5 patients with CMV viremia after antiviral prophylaxis treated with leflunomide and other antiviral agents. The horizontal axis in each frame shows the time course in days after renal transplant (Tx). The duration of antiviral prophylaxis and therapy with different antiviral agents is indicated by horizontal bars on the top of each frame. PPX = Prophylaxis (gray bars); GCV/VGCV (purple bars); LEF = leflunomide (orange bars); FOS = foscarnet (green bars); CID = brincidofovir (red bar).
case_images: cnd-0005-0096-g01.jpg
case_images: PMC4427155_05_cnd-0005-0096-g01.jpg
case_images: F1
case_images: HTN underwent a SPK in May 2001 (fig. 1e).
case_images: PMC4427155_05
case_images: Kinetics of viral load (red solid line) and Scr (blue dashed line) in 5 patients with CMV viremia after antiviral prophylaxis treated with leflunomide and other antiviral agents. The horizontal axis in each frame shows the time course in days after renal transplant (Tx). The duration of antiviral prophylaxis and therapy with different antiviral agents is indicated by horizontal bars on the top of each frame. PPX = Prophylaxis (gray bars); GCV/VGCV (purple bars); LEF = leflunomide (orange bars); FOS = foscarnet (green bars); CID = brincidofovir (red bar).
case_images: cnd-0005-0096-g01.jpg
case_images: PMC4427155_05_cnd-0005-0096-g01.jpg
case_images: F1
case_images: HTN underwent a SPK in May 2001 (fig. 1e).